Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.55 USD | +1.71% | +4.47% | +44.91% |
04-02 | ADMA Biologics, Inc. Announces Promotion of Kaitlin Kestenberg as Chief Operating Officer | CI |
03-26 | HC Wainwright Adjusts ADMA Biologics Price Target to $7.50 From $6, Maintains Buy Rating | MT |
Business Summary
Number of employees: 624
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
ADMA BioManufacturing
96.7
%
| 144 | 93.5 % | 250 | 96.7 % | +73.35% |
Plasma Collection Centers
3.2
%
| 10 | 6.4 % | 8 | 3.2 % | -15.54% |
Corporate Segment
0.1
%
| 0 | 0.1 % | 0 | 0.1 % | +0.12% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
94.8
%
| 146 | 95.0 % | 245 | 94.8 % | +67.24% |
International
5.2
%
| 8 | 5.0 % | 13 | 5.2 % | +74.23% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Adam Grossman
CEO | Chief Executive Officer | 47 | 06-06-01 |
Compliance Officer | 37 | 10-12-31 | |
Skyler Bloom
IRC | Investor Relations Contact | - | - |
Cindy Petersen
HRO | Human Resources Officer | - | 22-09-30 |
James Maloney
LAW | General Counsel | - | - |
Sales & Marketing | - | - | |
Lucy DeMario
PRN | Corporate Officer/Principal | - | - |
Michael Space
PRN | Corporate Officer/Principal | - | - |
General Counsel | - | 21-03-31 | |
General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lawrence Guiheen
BRD | Director/Board Member | 73 | 12-07-23 |
Bryant Fong
BRD | Director/Board Member | 51 | 12-04-30 |
Steven Elms
CHM | Chairman | 60 | 06-12-31 |
Alison Finger
BRD | Director/Board Member | 60 | 23-09-27 |
Jerrold Grossman
FOU | Founder | 76 | 06-06-01 |
Young Kwon
BRD | Director/Board Member | 52 | 21-10-14 |
Adam Grossman
CEO | Chief Executive Officer | 47 | 06-06-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 231,771,523 | 216,636,208 ( 93.47 %) | 0 | 93.47 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.91% | 1.52B | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- ADMA Stock
- Company ADMA Biologics, Inc.